nodes	percent_of_prediction	percent_of_DWPC	metapath
Losartan—ALB—Vismodegib—skin cancer	0.0728	0.0996	CbGbCtD
Losartan—CYP1A2—Imiquimod—skin cancer	0.0629	0.086	CbGbCtD
Losartan—SLCO1B3—Docetaxel—skin cancer	0.062	0.0847	CbGbCtD
Losartan—ALB—Vemurafenib—skin cancer	0.0576	0.0787	CbGbCtD
Losartan—CYP2C8—Vismodegib—skin cancer	0.0563	0.077	CbGbCtD
Losartan—CYP2C19—Vismodegib—skin cancer	0.0472	0.0646	CbGbCtD
Losartan—CYP2C9—Vismodegib—skin cancer	0.0393	0.0537	CbGbCtD
Losartan—ABCB1—Vismodegib—skin cancer	0.0381	0.0521	CbGbCtD
Losartan—CYP1A2—Vemurafenib—skin cancer	0.0344	0.0471	CbGbCtD
Losartan—CYP3A4—Temozolomide—skin cancer	0.0329	0.045	CbGbCtD
Losartan—CYP3A4—Imiquimod—skin cancer	0.0329	0.045	CbGbCtD
Losartan—CYP1A2—Dacarbazine—skin cancer	0.0264	0.0361	CbGbCtD
Losartan—ALB—Fluorouracil—skin cancer	0.0259	0.0354	CbGbCtD
Losartan—CYP3A4—Vismodegib—skin cancer	0.0228	0.0312	CbGbCtD
Losartan—ABCB1—Dactinomycin—skin cancer	0.02	0.0274	CbGbCtD
Losartan—CYP2C8—Fluorouracil—skin cancer	0.02	0.0273	CbGbCtD
Losartan—CYP3A4—Vemurafenib—skin cancer	0.018	0.0247	CbGbCtD
Losartan—CYP3A5—Docetaxel—skin cancer	0.0159	0.0217	CbGbCtD
Losartan—CYP1A2—Fluorouracil—skin cancer	0.0155	0.0212	CbGbCtD
Losartan—CYP2C9—Fluorouracil—skin cancer	0.0139	0.0191	CbGbCtD
Losartan—ABCB1—Docetaxel—skin cancer	0.0103	0.0141	CbGbCtD
Losartan—ACE—forelimb zeugopod—skin cancer	0.00751	0.109	CbGeAlD
Losartan—UGT2B17—epithelium—skin cancer	0.0063	0.0913	CbGeAlD
Losartan—CYP3A4—Docetaxel—skin cancer	0.00619	0.00847	CbGbCtD
Losartan—SLC2A9—hair follicle—skin cancer	0.00611	0.0886	CbGeAlD
Losartan—ACE—forelimb—skin cancer	0.00378	0.0547	CbGeAlD
Losartan—ACE—hindlimb—skin cancer	0.0034	0.0492	CbGeAlD
Losartan—ACE—arm—skin cancer	0.00324	0.047	CbGeAlD
Losartan—SLC2A9—connective tissue—skin cancer	0.00294	0.0426	CbGeAlD
Losartan—ACE—appendage—skin cancer	0.00291	0.0422	CbGeAlD
Losartan—AGTR1—endothelium—skin cancer	0.00238	0.0345	CbGeAlD
Losartan—AGTR1—blood vessel—skin cancer	0.0022	0.0318	CbGeAlD
Losartan—SLC2A9—female reproductive system—skin cancer	0.00207	0.03	CbGeAlD
Losartan—ACE—nerve—skin cancer	0.00207	0.0299	CbGeAlD
Losartan—ACE—endothelium—skin cancer	0.00176	0.0255	CbGeAlD
Losartan—ACE—blood vessel—skin cancer	0.00162	0.0235	CbGeAlD
Losartan—AGTR1—nipple—skin cancer	0.00159	0.023	CbGeAlD
Losartan—AGTR1—neck—skin cancer	0.00157	0.0228	CbGeAlD
Losartan—SLC2A9—lymph node—skin cancer	0.00121	0.0176	CbGeAlD
Losartan—ACE—neck—skin cancer	0.00116	0.0168	CbGeAlD
Losartan—AGTR1—connective tissue—skin cancer	0.00113	0.0163	CbGeAlD
Losartan—UGT2B7—female reproductive system—skin cancer	0.00107	0.0155	CbGeAlD
Losartan—AGTR1—epithelium—skin cancer	0.00107	0.0155	CbGeAlD
Losartan—ACE—connective tissue—skin cancer	0.000832	0.0121	CbGeAlD
Losartan—AGTR1—lymphoid tissue—skin cancer	0.000824	0.0119	CbGeAlD
Losartan—CYP1A2—nipple—skin cancer	0.000806	0.0117	CbGeAlD
Losartan—AGTR1—female reproductive system—skin cancer	0.000794	0.0115	CbGeAlD
Losartan—ACE—epithelium—skin cancer	0.00079	0.0114	CbGeAlD
Losartan—SLCO1B1—female reproductive system—skin cancer	0.000757	0.011	CbGeAlD
Losartan—ACE—mammalian vulva—skin cancer	0.000685	0.00993	CbGeAlD
Losartan—AGTR1—head—skin cancer	0.000664	0.00962	CbGeAlD
Losartan—ACE—lymphoid tissue—skin cancer	0.000608	0.00881	CbGeAlD
Losartan—ACE—female reproductive system—skin cancer	0.000586	0.0085	CbGeAlD
Losartan—ABCB1—blood vessel—skin cancer	0.000571	0.00828	CbGeAlD
Losartan—ACE—head—skin cancer	0.00049	0.0071	CbGeAlD
Losartan—AGTR1—lymph node—skin cancer	0.000465	0.00673	CbGeAlD
Losartan—CYP2C8—female reproductive system—skin cancer	0.000431	0.00624	CbGeAlD
Losartan—CYP2C9—female reproductive system—skin cancer	0.000383	0.00554	CbGeAlD
Losartan—ALB—lymph node—skin cancer	0.000358	0.0052	CbGeAlD
Losartan—Sinusitis—Fluorouracil—skin cancer	0.000344	0.00172	CcSEcCtD
Losartan—Erythema—Dactinomycin—skin cancer	0.000344	0.00172	CcSEcCtD
Losartan—Pain in extremity—Docetaxel—skin cancer	0.000343	0.00172	CcSEcCtD
Losartan—ACE—lymph node—skin cancer	0.000343	0.00497	CbGeAlD
Losartan—Agranulocytosis—Fluorouracil—skin cancer	0.000342	0.00171	CcSEcCtD
Losartan—Ill-defined disorder—Bleomycin—skin cancer	0.000342	0.00171	CcSEcCtD
Losartan—Anaemia—Bleomycin—skin cancer	0.000341	0.00171	CcSEcCtD
Losartan—Diarrhoea—Vemurafenib—skin cancer	0.00034	0.0017	CcSEcCtD
Losartan—Migraine—Docetaxel—skin cancer	0.000338	0.00169	CcSEcCtD
Losartan—Erythema multiforme—Temozolomide—skin cancer	0.000338	0.00169	CcSEcCtD
Losartan—Urticaria—Imiquimod—skin cancer	0.000336	0.00169	CcSEcCtD
Losartan—Body temperature increased—Imiquimod—skin cancer	0.000335	0.00168	CcSEcCtD
Losartan—Abdominal pain—Imiquimod—skin cancer	0.000335	0.00168	CcSEcCtD
Losartan—Tinnitus—Temozolomide—skin cancer	0.000333	0.00167	CcSEcCtD
Losartan—Malaise—Bleomycin—skin cancer	0.000332	0.00167	CcSEcCtD
Losartan—Flushing—Temozolomide—skin cancer	0.000332	0.00166	CcSEcCtD
Losartan—Leukopenia—Bleomycin—skin cancer	0.00033	0.00165	CcSEcCtD
Losartan—Rhinitis—Fluorouracil—skin cancer	0.00033	0.00165	CcSEcCtD
Losartan—Dizziness—Vemurafenib—skin cancer	0.000328	0.00165	CcSEcCtD
Losartan—Hypoaesthesia—Fluorouracil—skin cancer	0.000327	0.00164	CcSEcCtD
Losartan—Pharyngitis—Fluorouracil—skin cancer	0.000327	0.00164	CcSEcCtD
Losartan—Angiopathy—Temozolomide—skin cancer	0.000324	0.00162	CcSEcCtD
Losartan—Ataxia—Docetaxel—skin cancer	0.000323	0.00162	CcSEcCtD
Losartan—Cough—Bleomycin—skin cancer	0.000322	0.00161	CcSEcCtD
Losartan—Ill-defined disorder—Dactinomycin—skin cancer	0.000319	0.0016	CcSEcCtD
Losartan—Anaemia—Dactinomycin—skin cancer	0.000318	0.00159	CcSEcCtD
Losartan—Vomiting—Vemurafenib—skin cancer	0.000316	0.00158	CcSEcCtD
Losartan—Alopecia—Temozolomide—skin cancer	0.000316	0.00158	CcSEcCtD
Losartan—Dry skin—Docetaxel—skin cancer	0.000315	0.00158	CcSEcCtD
Losartan—Myalgia—Bleomycin—skin cancer	0.000314	0.00157	CcSEcCtD
Losartan—Chest pain—Bleomycin—skin cancer	0.000314	0.00157	CcSEcCtD
Losartan—Orthostatic hypotension—Docetaxel—skin cancer	0.000314	0.00157	CcSEcCtD
Losartan—Rash—Vemurafenib—skin cancer	0.000313	0.00157	CcSEcCtD
Losartan—Dermatitis—Vemurafenib—skin cancer	0.000313	0.00157	CcSEcCtD
Losartan—Hypersensitivity—Imiquimod—skin cancer	0.000312	0.00156	CcSEcCtD
Losartan—Headache—Vemurafenib—skin cancer	0.000311	0.00156	CcSEcCtD
Losartan—Erythema—Temozolomide—skin cancer	0.000311	0.00156	CcSEcCtD
Losartan—Breast disorder—Docetaxel—skin cancer	0.00031	0.00156	CcSEcCtD
Losartan—Discomfort—Bleomycin—skin cancer	0.00031	0.00155	CcSEcCtD
Losartan—Malaise—Dactinomycin—skin cancer	0.00031	0.00155	CcSEcCtD
Losartan—Cramp muscle—Docetaxel—skin cancer	0.000309	0.00155	CcSEcCtD
Losartan—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000309	0.00155	CcSEcCtD
Losartan—Leukopenia—Dactinomycin—skin cancer	0.000308	0.00154	CcSEcCtD
Losartan—Dysgeusia—Temozolomide—skin cancer	0.000305	0.00153	CcSEcCtD
Losartan—Asthenia—Imiquimod—skin cancer	0.000304	0.00152	CcSEcCtD
Losartan—Confusional state—Bleomycin—skin cancer	0.000303	0.00152	CcSEcCtD
Losartan—Anaphylactic shock—Bleomycin—skin cancer	0.000301	0.00151	CcSEcCtD
Losartan—Oedema—Bleomycin—skin cancer	0.000301	0.00151	CcSEcCtD
Losartan—Back pain—Temozolomide—skin cancer	0.000301	0.00151	CcSEcCtD
Losartan—Pruritus—Imiquimod—skin cancer	0.0003	0.0015	CcSEcCtD
Losartan—Infection—Bleomycin—skin cancer	0.000299	0.0015	CcSEcCtD
Losartan—Nausea—Vemurafenib—skin cancer	0.000295	0.00148	CcSEcCtD
Losartan—Thrombocytopenia—Bleomycin—skin cancer	0.000295	0.00148	CcSEcCtD
Losartan—Arrhythmia—Fluorouracil—skin cancer	0.000294	0.00147	CcSEcCtD
Losartan—Vision blurred—Temozolomide—skin cancer	0.000293	0.00147	CcSEcCtD
Losartan—Myalgia—Dactinomycin—skin cancer	0.000293	0.00147	CcSEcCtD
Losartan—CYP3A4—female reproductive system—skin cancer	0.000292	0.00423	CbGeAlD
Losartan—Tremor—Temozolomide—skin cancer	0.000291	0.00146	CcSEcCtD
Losartan—Alopecia—Fluorouracil—skin cancer	0.000291	0.00146	CcSEcCtD
Losartan—Diarrhoea—Imiquimod—skin cancer	0.00029	0.00145	CcSEcCtD
Losartan—Discomfort—Dactinomycin—skin cancer	0.000289	0.00145	CcSEcCtD
Losartan—Angina pectoris—Docetaxel—skin cancer	0.000289	0.00145	CcSEcCtD
Losartan—Ill-defined disorder—Temozolomide—skin cancer	0.000289	0.00145	CcSEcCtD
Losartan—Anaemia—Temozolomide—skin cancer	0.000287	0.00144	CcSEcCtD
Losartan—Anorexia—Bleomycin—skin cancer	0.000287	0.00144	CcSEcCtD
Losartan—Erythema—Fluorouracil—skin cancer	0.000287	0.00144	CcSEcCtD
Losartan—Agitation—Temozolomide—skin cancer	0.000286	0.00143	CcSEcCtD
Losartan—Angioedema—Temozolomide—skin cancer	0.000284	0.00142	CcSEcCtD
Losartan—Hypotension—Bleomycin—skin cancer	0.000281	0.00141	CcSEcCtD
Losartan—Oedema—Dactinomycin—skin cancer	0.000281	0.00141	CcSEcCtD
Losartan—Malaise—Temozolomide—skin cancer	0.00028	0.00141	CcSEcCtD
Losartan—Dizziness—Imiquimod—skin cancer	0.00028	0.0014	CcSEcCtD
Losartan—Vertigo—Temozolomide—skin cancer	0.000279	0.0014	CcSEcCtD
Losartan—Infection—Dactinomycin—skin cancer	0.000279	0.0014	CcSEcCtD
Losartan—Leukopenia—Temozolomide—skin cancer	0.000278	0.00139	CcSEcCtD
Losartan—ABCB1—epithelium—skin cancer	0.000278	0.00403	CbGeAlD
Losartan—Palpitations—Temozolomide—skin cancer	0.000275	0.00138	CcSEcCtD
Losartan—Thrombocytopenia—Dactinomycin—skin cancer	0.000275	0.00138	CcSEcCtD
Losartan—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000274	0.00137	CcSEcCtD
Losartan—Cough—Temozolomide—skin cancer	0.000271	0.00136	CcSEcCtD
Losartan—Paraesthesia—Bleomycin—skin cancer	0.00027	0.00135	CcSEcCtD
Losartan—Weight increased—Docetaxel—skin cancer	0.00027	0.00135	CcSEcCtD
Losartan—Vision blurred—Fluorouracil—skin cancer	0.00027	0.00135	CcSEcCtD
Losartan—Vomiting—Imiquimod—skin cancer	0.000269	0.00135	CcSEcCtD
Losartan—Dyspnoea—Bleomycin—skin cancer	0.000268	0.00134	CcSEcCtD
Losartan—Anorexia—Dactinomycin—skin cancer	0.000267	0.00134	CcSEcCtD
Losartan—Rash—Imiquimod—skin cancer	0.000267	0.00134	CcSEcCtD
Losartan—Dermatitis—Imiquimod—skin cancer	0.000267	0.00134	CcSEcCtD
Losartan—Pneumonia—Docetaxel—skin cancer	0.000266	0.00133	CcSEcCtD
Losartan—Headache—Imiquimod—skin cancer	0.000265	0.00133	CcSEcCtD
Losartan—Anaemia—Fluorouracil—skin cancer	0.000265	0.00133	CcSEcCtD
Losartan—Arthralgia—Temozolomide—skin cancer	0.000265	0.00133	CcSEcCtD
Losartan—Myalgia—Temozolomide—skin cancer	0.000265	0.00133	CcSEcCtD
Losartan—Anxiety—Temozolomide—skin cancer	0.000264	0.00132	CcSEcCtD
Losartan—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000262	0.00131	CcSEcCtD
Losartan—Discomfort—Temozolomide—skin cancer	0.000262	0.00131	CcSEcCtD
Losartan—Decreased appetite—Bleomycin—skin cancer	0.000262	0.00131	CcSEcCtD
Losartan—Renal failure—Docetaxel—skin cancer	0.00026	0.0013	CcSEcCtD
Losartan—Neuropathy peripheral—Docetaxel—skin cancer	0.000259	0.0013	CcSEcCtD
Losartan—Dry mouth—Temozolomide—skin cancer	0.000259	0.0013	CcSEcCtD
Losartan—Jaundice—Docetaxel—skin cancer	0.000258	0.00129	CcSEcCtD
Losartan—Pain—Bleomycin—skin cancer	0.000257	0.00129	CcSEcCtD
Losartan—Conjunctivitis—Docetaxel—skin cancer	0.000257	0.00129	CcSEcCtD
Losartan—Leukopenia—Fluorouracil—skin cancer	0.000256	0.00129	CcSEcCtD
Losartan—Confusional state—Temozolomide—skin cancer	0.000256	0.00128	CcSEcCtD
Losartan—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000256	0.00128	CcSEcCtD
Losartan—Oedema—Temozolomide—skin cancer	0.000254	0.00127	CcSEcCtD
Losartan—Anaphylactic shock—Temozolomide—skin cancer	0.000254	0.00127	CcSEcCtD
Losartan—Infection—Temozolomide—skin cancer	0.000252	0.00126	CcSEcCtD
Losartan—Nausea—Imiquimod—skin cancer	0.000252	0.00126	CcSEcCtD
Losartan—Epistaxis—Docetaxel—skin cancer	0.00025	0.00125	CcSEcCtD
Losartan—Nervous system disorder—Temozolomide—skin cancer	0.000249	0.00125	CcSEcCtD
Losartan—Thrombocytopenia—Temozolomide—skin cancer	0.000248	0.00125	CcSEcCtD
Losartan—Feeling abnormal—Bleomycin—skin cancer	0.000248	0.00124	CcSEcCtD
Losartan—Agranulocytosis—Docetaxel—skin cancer	0.000247	0.00124	CcSEcCtD
Losartan—Hyperhidrosis—Temozolomide—skin cancer	0.000245	0.00123	CcSEcCtD
Losartan—Myalgia—Fluorouracil—skin cancer	0.000244	0.00122	CcSEcCtD
Losartan—Chest pain—Fluorouracil—skin cancer	0.000244	0.00122	CcSEcCtD
Losartan—Decreased appetite—Dactinomycin—skin cancer	0.000244	0.00122	CcSEcCtD
Losartan—Fatigue—Dactinomycin—skin cancer	0.000242	0.00121	CcSEcCtD
Losartan—Anorexia—Temozolomide—skin cancer	0.000242	0.00121	CcSEcCtD
Losartan—ABCB1—mammalian vulva—skin cancer	0.000241	0.00349	CbGeAlD
Losartan—Discomfort—Fluorouracil—skin cancer	0.000241	0.00121	CcSEcCtD
Losartan—Pain—Dactinomycin—skin cancer	0.00024	0.0012	CcSEcCtD
Losartan—Urticaria—Bleomycin—skin cancer	0.000239	0.0012	CcSEcCtD
Losartan—Rhinitis—Docetaxel—skin cancer	0.000238	0.00119	CcSEcCtD
Losartan—Body temperature increased—Bleomycin—skin cancer	0.000238	0.00119	CcSEcCtD
Losartan—Hepatitis—Docetaxel—skin cancer	0.000238	0.00119	CcSEcCtD
Losartan—Hypoaesthesia—Docetaxel—skin cancer	0.000236	0.00118	CcSEcCtD
Losartan—Confusional state—Fluorouracil—skin cancer	0.000236	0.00118	CcSEcCtD
Losartan—Pharyngitis—Docetaxel—skin cancer	0.000236	0.00118	CcSEcCtD
Losartan—Anaphylactic shock—Fluorouracil—skin cancer	0.000234	0.00117	CcSEcCtD
Losartan—Oedema—Fluorouracil—skin cancer	0.000234	0.00117	CcSEcCtD
Losartan—Infection—Fluorouracil—skin cancer	0.000232	0.00116	CcSEcCtD
Losartan—Feeling abnormal—Dactinomycin—skin cancer	0.000231	0.00116	CcSEcCtD
Losartan—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000231	0.00116	CcSEcCtD
Losartan—Insomnia—Temozolomide—skin cancer	0.00023	0.00115	CcSEcCtD
Losartan—Gastrointestinal pain—Dactinomycin—skin cancer	0.000229	0.00115	CcSEcCtD
Losartan—Nervous system disorder—Fluorouracil—skin cancer	0.000229	0.00115	CcSEcCtD
Losartan—Thrombocytopenia—Fluorouracil—skin cancer	0.000229	0.00115	CcSEcCtD
Losartan—Tachycardia—Fluorouracil—skin cancer	0.000228	0.00114	CcSEcCtD
Losartan—Paraesthesia—Temozolomide—skin cancer	0.000228	0.00114	CcSEcCtD
Losartan—Dyspnoea—Temozolomide—skin cancer	0.000226	0.00113	CcSEcCtD
Losartan—Somnolence—Temozolomide—skin cancer	0.000226	0.00113	CcSEcCtD
Losartan—Erythema multiforme—Docetaxel—skin cancer	0.000225	0.00113	CcSEcCtD
Losartan—Dyspepsia—Temozolomide—skin cancer	0.000223	0.00112	CcSEcCtD
Losartan—Anorexia—Fluorouracil—skin cancer	0.000223	0.00112	CcSEcCtD
Losartan—Abdominal pain—Dactinomycin—skin cancer	0.000222	0.00111	CcSEcCtD
Losartan—Body temperature increased—Dactinomycin—skin cancer	0.000222	0.00111	CcSEcCtD
Losartan—Hypersensitivity—Bleomycin—skin cancer	0.000222	0.00111	CcSEcCtD
Losartan—Decreased appetite—Temozolomide—skin cancer	0.000221	0.00111	CcSEcCtD
Losartan—Flushing—Docetaxel—skin cancer	0.00022	0.0011	CcSEcCtD
Losartan—Fatigue—Temozolomide—skin cancer	0.000219	0.0011	CcSEcCtD
Losartan—Hypotension—Fluorouracil—skin cancer	0.000218	0.00109	CcSEcCtD
Losartan—Pain—Temozolomide—skin cancer	0.000217	0.00109	CcSEcCtD
Losartan—Constipation—Temozolomide—skin cancer	0.000217	0.00109	CcSEcCtD
Losartan—Asthenia—Bleomycin—skin cancer	0.000216	0.00108	CcSEcCtD
Losartan—Angiopathy—Docetaxel—skin cancer	0.000216	0.00108	CcSEcCtD
Losartan—ABCB1—lymphoid tissue—skin cancer	0.000214	0.0031	CbGeAlD
Losartan—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000213	0.00107	CcSEcCtD
Losartan—Pruritus—Bleomycin—skin cancer	0.000213	0.00107	CcSEcCtD
Losartan—Arrhythmia—Docetaxel—skin cancer	0.000212	0.00106	CcSEcCtD
Losartan—Insomnia—Fluorouracil—skin cancer	0.000211	0.00106	CcSEcCtD
Losartan—Paraesthesia—Fluorouracil—skin cancer	0.00021	0.00105	CcSEcCtD
Losartan—Alopecia—Docetaxel—skin cancer	0.00021	0.00105	CcSEcCtD
Losartan—Feeling abnormal—Temozolomide—skin cancer	0.000209	0.00105	CcSEcCtD
Losartan—Dyspnoea—Fluorouracil—skin cancer	0.000208	0.00104	CcSEcCtD
Losartan—Somnolence—Fluorouracil—skin cancer	0.000208	0.00104	CcSEcCtD
Losartan—Gastrointestinal pain—Temozolomide—skin cancer	0.000208	0.00104	CcSEcCtD
Losartan—Erythema—Docetaxel—skin cancer	0.000207	0.00104	CcSEcCtD
Losartan—Hypersensitivity—Dactinomycin—skin cancer	0.000207	0.00104	CcSEcCtD
Losartan—ABCB1—female reproductive system—skin cancer	0.000206	0.00299	CbGeAlD
Losartan—Dyspepsia—Fluorouracil—skin cancer	0.000206	0.00103	CcSEcCtD
Losartan—Decreased appetite—Fluorouracil—skin cancer	0.000203	0.00102	CcSEcCtD
Losartan—Dysgeusia—Docetaxel—skin cancer	0.000203	0.00101	CcSEcCtD
Losartan—Urticaria—Temozolomide—skin cancer	0.000202	0.00101	CcSEcCtD
Losartan—Asthenia—Dactinomycin—skin cancer	0.000201	0.00101	CcSEcCtD
Losartan—Body temperature increased—Temozolomide—skin cancer	0.000201	0.00101	CcSEcCtD
Losartan—Abdominal pain—Temozolomide—skin cancer	0.000201	0.00101	CcSEcCtD
Losartan—Back pain—Docetaxel—skin cancer	0.0002	0.001	CcSEcCtD
Losartan—Pain—Fluorouracil—skin cancer	0.0002	0.001	CcSEcCtD
Losartan—Muscle spasms—Docetaxel—skin cancer	0.000199	0.000996	CcSEcCtD
Losartan—Feeling abnormal—Fluorouracil—skin cancer	0.000193	0.000966	CcSEcCtD
Losartan—Diarrhoea—Dactinomycin—skin cancer	0.000192	0.000962	CcSEcCtD
Losartan—Vomiting—Bleomycin—skin cancer	0.000191	0.000959	CcSEcCtD
Losartan—Anaemia—Docetaxel—skin cancer	0.000191	0.000958	CcSEcCtD
Losartan—Rash—Bleomycin—skin cancer	0.00019	0.000951	CcSEcCtD
Losartan—Dermatitis—Bleomycin—skin cancer	0.00019	0.00095	CcSEcCtD
Losartan—Hypersensitivity—Temozolomide—skin cancer	0.000187	0.000937	CcSEcCtD
Losartan—Urticaria—Fluorouracil—skin cancer	0.000186	0.000931	CcSEcCtD
Losartan—Syncope—Docetaxel—skin cancer	0.000185	0.000929	CcSEcCtD
Losartan—Leukopenia—Docetaxel—skin cancer	0.000185	0.000928	CcSEcCtD
Losartan—Body temperature increased—Fluorouracil—skin cancer	0.000185	0.000926	CcSEcCtD
Losartan—Palpitations—Docetaxel—skin cancer	0.000183	0.000916	CcSEcCtD
Losartan—Asthenia—Temozolomide—skin cancer	0.000182	0.000912	CcSEcCtD
Losartan—Loss of consciousness—Docetaxel—skin cancer	0.000182	0.000911	CcSEcCtD
Losartan—Cough—Docetaxel—skin cancer	0.00018	0.000904	CcSEcCtD
Losartan—Pruritus—Temozolomide—skin cancer	0.00018	0.0009	CcSEcCtD
Losartan—Nausea—Bleomycin—skin cancer	0.000179	0.000896	CcSEcCtD
Losartan—Vomiting—Dactinomycin—skin cancer	0.000178	0.000894	CcSEcCtD
Losartan—Rash—Dactinomycin—skin cancer	0.000177	0.000887	CcSEcCtD
Losartan—Myalgia—Docetaxel—skin cancer	0.000176	0.000882	CcSEcCtD
Losartan—Chest pain—Docetaxel—skin cancer	0.000176	0.000882	CcSEcCtD
Losartan—Arthralgia—Docetaxel—skin cancer	0.000176	0.000882	CcSEcCtD
Losartan—Diarrhoea—Temozolomide—skin cancer	0.000174	0.00087	CcSEcCtD
Losartan—ABCB1—head—skin cancer	0.000172	0.0025	CbGeAlD
Losartan—Hypersensitivity—Fluorouracil—skin cancer	0.000172	0.000863	CcSEcCtD
Losartan—Dry mouth—Docetaxel—skin cancer	0.000172	0.000863	CcSEcCtD
Losartan—Confusional state—Docetaxel—skin cancer	0.00017	0.000853	CcSEcCtD
Losartan—Oedema—Docetaxel—skin cancer	0.000169	0.000846	CcSEcCtD
Losartan—Anaphylactic shock—Docetaxel—skin cancer	0.000169	0.000846	CcSEcCtD
Losartan—Dizziness—Temozolomide—skin cancer	0.000168	0.000841	CcSEcCtD
Losartan—Infection—Docetaxel—skin cancer	0.000168	0.00084	CcSEcCtD
Losartan—Nausea—Dactinomycin—skin cancer	0.000167	0.000835	CcSEcCtD
Losartan—Shock—Docetaxel—skin cancer	0.000166	0.000832	CcSEcCtD
Losartan—Nervous system disorder—Docetaxel—skin cancer	0.000166	0.000829	CcSEcCtD
Losartan—Pruritus—Fluorouracil—skin cancer	0.000165	0.000829	CcSEcCtD
Losartan—Thrombocytopenia—Docetaxel—skin cancer	0.000165	0.000828	CcSEcCtD
Losartan—Tachycardia—Docetaxel—skin cancer	0.000165	0.000825	CcSEcCtD
Losartan—Vomiting—Temozolomide—skin cancer	0.000161	0.000809	CcSEcCtD
Losartan—Anorexia—Docetaxel—skin cancer	0.000161	0.000806	CcSEcCtD
Losartan—Rash—Temozolomide—skin cancer	0.00016	0.000802	CcSEcCtD
Losartan—Diarrhoea—Fluorouracil—skin cancer	0.00016	0.000802	CcSEcCtD
Losartan—Dermatitis—Temozolomide—skin cancer	0.00016	0.000801	CcSEcCtD
Losartan—Headache—Temozolomide—skin cancer	0.000159	0.000797	CcSEcCtD
Losartan—Hypotension—Docetaxel—skin cancer	0.000158	0.00079	CcSEcCtD
Losartan—Dizziness—Fluorouracil—skin cancer	0.000155	0.000775	CcSEcCtD
Losartan—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000154	0.000771	CcSEcCtD
Losartan—Insomnia—Docetaxel—skin cancer	0.000153	0.000765	CcSEcCtD
Losartan—Paraesthesia—Docetaxel—skin cancer	0.000152	0.000759	CcSEcCtD
Losartan—Nausea—Temozolomide—skin cancer	0.000151	0.000755	CcSEcCtD
Losartan—Dyspnoea—Docetaxel—skin cancer	0.00015	0.000754	CcSEcCtD
Losartan—Somnolence—Docetaxel—skin cancer	0.00015	0.000752	CcSEcCtD
Losartan—Vomiting—Fluorouracil—skin cancer	0.000149	0.000745	CcSEcCtD
Losartan—Dyspepsia—Docetaxel—skin cancer	0.000149	0.000744	CcSEcCtD
Losartan—Rash—Fluorouracil—skin cancer	0.000147	0.000739	CcSEcCtD
Losartan—Dermatitis—Fluorouracil—skin cancer	0.000147	0.000738	CcSEcCtD
Losartan—Decreased appetite—Docetaxel—skin cancer	0.000147	0.000735	CcSEcCtD
Losartan—Headache—Fluorouracil—skin cancer	0.000146	0.000734	CcSEcCtD
Losartan—Fatigue—Docetaxel—skin cancer	0.000146	0.000729	CcSEcCtD
Losartan—Constipation—Docetaxel—skin cancer	0.000144	0.000723	CcSEcCtD
Losartan—Pain—Docetaxel—skin cancer	0.000144	0.000723	CcSEcCtD
Losartan—Feeling abnormal—Docetaxel—skin cancer	0.000139	0.000697	CcSEcCtD
Losartan—Nausea—Fluorouracil—skin cancer	0.000139	0.000696	CcSEcCtD
Losartan—Gastrointestinal pain—Docetaxel—skin cancer	0.000138	0.000692	CcSEcCtD
Losartan—Abdominal pain—Docetaxel—skin cancer	0.000133	0.000669	CcSEcCtD
Losartan—Body temperature increased—Docetaxel—skin cancer	0.000133	0.000669	CcSEcCtD
Losartan—Hypersensitivity—Docetaxel—skin cancer	0.000124	0.000623	CcSEcCtD
Losartan—Asthenia—Docetaxel—skin cancer	0.000121	0.000607	CcSEcCtD
Losartan—ABCB1—lymph node—skin cancer	0.000121	0.00175	CbGeAlD
Losartan—Pruritus—Docetaxel—skin cancer	0.000119	0.000598	CcSEcCtD
Losartan—Diarrhoea—Docetaxel—skin cancer	0.000115	0.000579	CcSEcCtD
Losartan—Dizziness—Docetaxel—skin cancer	0.000112	0.000559	CcSEcCtD
Losartan—Vomiting—Docetaxel—skin cancer	0.000107	0.000538	CcSEcCtD
Losartan—Rash—Docetaxel—skin cancer	0.000106	0.000533	CcSEcCtD
Losartan—Dermatitis—Docetaxel—skin cancer	0.000106	0.000533	CcSEcCtD
Losartan—Headache—Docetaxel—skin cancer	0.000106	0.00053	CcSEcCtD
Losartan—Nausea—Docetaxel—skin cancer	0.0001	0.000502	CcSEcCtD
